- BBS Pharmaceuticals Contact
- contact@bbspharmaceuticals.com
BBS Pharmaceuticals News
Export Control Legislation Amendment (Certification of Narcotic Exports) Bill passes in Australia… - BBS Pharmaceuticals, a licensed cultivator and manufacturer of medicinal cannabis products would like to congratulate Minister David Littleproud and the… […]
Adrian Pederick MP applauds BBS on their site progress… - It has been a busy and productive start of the second quarter here at BBS Pharmaceuticals. We had the honour… […]
Regional Development Australia Murraylands & Riverland impressed with BBS’s progress - It has been a busy and incredibly productive start of the week here at BBS as we are entering the… […] Local MP, Adrian Pederick visits BBS’s facility… - It has been a busy and productive start of the second quarter here at BBS Pharmaceuticals. We had the honour… […]
Minister for Trade and Investment, David Ridgway visits BBS’s facility - It was our great honour to host The Hon. David Ridgway, Minister of Trade and Investment, at BBS’s cultivation and… […]
Australian government unveils proposal for over-the-counter CBD - Australia has published a framework for new CBD regulations as it considers relaxing its narcotics scheduling of cannabidiol to make… […]
BBS Pharmaceuticals welcomes newly appointed Head of Sales & Marketing - Michael Kromwyk has been appointed Head of Sales and Marketing at BBS Pharmaceuticals with responsibility for brand and marketing programs,… […]
BBS’s CEO John Dagas addresses Covid -19 and moving forward… - These are challenging times as the world responds to the coronavirus outbreak and sets a path to recovery. First off,… […]
Australia’s legal cannabis market predicted to bloom to $1.5 billion by 2025 - As various phases of legalisation come into effect in different parts of Australia, the country’s cannabis market is expected to… […]
Industry Breakthough as Australian Senate Committee pushes for legalisation and increased patient access to medicinal cannabis in Australia! - The Australian Senate Committee has revealed their recommendations from the inquiry 'Current barriers to patient access to medicinal cannabis in… […]
BBS’s Primary growth strategy is to connect with the export markets. As a leader in the market of medicinal cannabis, BBS is focusing on establishing regional […]
BBS Pharmaceuticals CEO, John Dagas has been elected on the Hellenic Biocluster Board. Based in Athens, Hellenic Biocluster the first biosciences cluster in Greece bringing together […]
The global cannabis market is expected to reach US$ 153,689.9 Mn in 2027 from US$ 10,838.1 in 2018. The market is estimated to grow with a […]
If Australia’s aspiration to become the world’s largest exporter of medicinal cannabis is to be realised, then a further review of the licence regime is required. […]
Thousands of Australians are now using medicinal cannabis to treat conditions like chronic pain and anorexia. Last February, the ABC revealed more than 3,100 medicinal cannabis […]
Cannabidiol-enriched cannabis use in pediatric treatment helps with mental health and treatment-resistant epilepsy. Severe childhood epilepsies are characterized by frequent seizures, neurodevelopmental delays, and impaired quality […]
BBS Pharmaceuticals has been recognised as a key player in the global cannabis market according to a recent report published by Oriana Research. Cannabis Capsule Market […]
Cannabis has been used for medicinal purposes for centuries, but despite the therapeutic benefits of the plant, international regulators ultimately deemed it unsafe for the public […]
According to New Frontier Data, the legalization of cannabis may prove to be one of the most consequential social changes of our time, and governments, investors, […]